Jacob W. Brubaker, MD received his medical degree from McGill University. He went on to complete an internship in Internal Medicine at the University of Utah and his ophthalmology residency at the University of Missouri. He completed two fellowships, one in ophthalmic pathology at the University of Utah and his glaucoma fellowship at the Dean McGee Eye Institute, University of Oklahoma.
He chose the specialty of glaucoma because of the complexity of the disease and the challenge it presents. He is fascinated with the technological advancements made in recent years and being deeply involved in clinical research, which have made glaucoma treatment and outcomes increasingly more rewarding. So far in his career he has served as principle investigator on many FDA studies, including many glaucoma approved devices and medications that have greatly advanced the care of glaucoma patients. Some of these include Hydrus, iStent, iDose, Rhopressa, Rocklatan, Durysta, among many others. Not only has Dr. Brubaker participated in several studies he also has an extensive list of publications, presentations, and awards for his research.
Dr. Brubaker has participated in ophthalmology medical missions to Port-au-Prince, Haiti, Senegal and Ghana, Africa and has also also volunteered in Quebec, Canada for 2 years. He finds fulfillment when he can offer assistance to people who suffer from challenging circumstances. Along with his wonderful work outside of the United States, Dr. Brubaker continues to be involved in leadership of National Ophthalmology Societies and present regularly at national meetings.
Dr. Brubaker is married and the father of four children. When he is not in the office he enjoys cooking, gardening, photography, and spending time with his family. He also is an outdoor sports enthusiast and loves backpacking, camping, skiing, and mountain biking.
Click here to read Dr. Brubaker's CV